These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6781917)

  • 21. Low-dose benznidazole treatment results in parasite clearance and attenuates heart inflammatory reaction in an experimental model of infection with a highly virulent Trypanosoma cruzi strain.
    Cevey ÁC; Mirkin GA; Penas FN; Goren NB
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):12-22. PubMed ID: 26862474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice.
    Ben Younès-Chennoufi A; Hontebeyrie-Joskowicz M; Tricottet V; Eisen H; Reynes M; Said G
    Trans R Soc Trop Med Hyg; 1988; 82(1):77-83. PubMed ID: 3140446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiological treatment for infection by Trypanosoma cruzi.
    Amato Neto V
    Rev Inst Med Trop Sao Paulo; 1999; 41(4):211-3. PubMed ID: 10564912
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of pyrazolopyrimidine ribonucleosides against Trypanosoma cruzi: studies in vitro and in vivo with sensitive and resistant strains.
    Berens RL; Marr JJ; Looker DL; Nelson DJ; LaFon SW
    J Infect Dis; 1984 Oct; 150(4):602-8. PubMed ID: 6436394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of allopurinol ribonucleoside and formycin B on Trypanosoma cruzi infections in mice.
    Croft SL; Neal RA
    Trans R Soc Trop Med Hyg; 1985; 79(4):517-8. PubMed ID: 3936241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma cruzi infection of human induced pluripotent stem cell-derived cardiomyocytes: an in vitro model for drug screening for Chagas disease.
    da Silva Lara L; Andrade-Lima L; Magalhães Calvet C; Borsoi J; Lopes Alberto Duque T; Henriques-Pons A; Souza Pereira MC; Veiga Pereira L
    Microbes Infect; 2018 May; 20(5):312-316. PubMed ID: 29577969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Part VI. Antiparasitic treatment for Chagas disease].
    B WA; G IH; L MI; M LJ; V PM; H IN; V AM; P JS; H MT; A IZ
    Rev Chilena Infectol; 2008 Oct; 25(5):384-9, discussion 387. PubMed ID: 18949153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One fate of bloodstream trypomastigote forms of Trypanosoma cruzi after immune clearance: an ultrastructural study.
    Umekita LF; Carneiro SM; Sesso A; Mota I
    J Parasitol; 1999 Oct; 85(5):867-72. PubMed ID: 10577722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [In vivo and in vitro susceptibility of Trypanosoma cruzi to ketoconazole].
    Rubiolo ER; Cano RC
    Rev Latinoam Microbiol; 1987; 29(4):395-401. PubMed ID: 3149794
    [No Abstract]   [Full Text] [Related]  

  • 31. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunomodulatory effects of the Enalapril in combination with Benznidazole during acute and chronic phases of the experimental infection with Trypanosoma cruzi.
    Leite ALJ; Paula Costa G; Lopes LR; Reis Mota LWD; Vieira PMA; Talvani A
    Acta Trop; 2017 Oct; 174():136-145. PubMed ID: 28720491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of immunosuppression and benzonidazole on Trypanosoma cruzi parasitism during experimental acute Chagas' disease.
    Okumura M; Mester M; Iriya K; Amato Neto V; Gama-Rodrigues J
    Transplant Proc; 1994 Jun; 26(3):1587-9. PubMed ID: 8030049
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug Discovery for Paediatric Chagas Disease.
    Thota S; Morel CM
    Mini Rev Med Chem; 2018; 18(9):776-780. PubMed ID: 26202205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment.
    Apt W; Arribada A; Zulantay I; Solari A; Sánchez G; Mundaca K; Coronado X; Rodríguez J; Gil LC; Osuna A
    Ann Trop Med Parasitol; 2005 Dec; 99(8):733-41. PubMed ID: 16297286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi infection and benznidazole therapy independently stimulate oxidative status and structural pathological remodeling of the liver tissue in mice.
    Novaes RD; Santos EC; Cupertino MC; Bastos DS; Oliveira JM; Carvalho TV; Neves MM; Oliveira LL; Talvani A
    Parasitol Res; 2015 Aug; 114(8):2873-81. PubMed ID: 25912691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ketoconazole protects against infection with Trypanosoma cruzi in a murine model.
    McCabe RE; Araujo FG; Remington JS
    Am J Trop Med Hyg; 1983 Sep; 32(5):960-2. PubMed ID: 6312824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One fate of epimastigote forms of Trypanosoma cruzi injected in mice. An ultrastructural study.
    Umekita LF; Carneiro SM; Mota I
    J Parasitol; 1998 Dec; 84(6):1190-5. PubMed ID: 9920312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
    Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anticancer drug tamoxifen is active against Trypanosoma cruzi in vitro but ineffective in the treatment of the acute phase of Chagas disease in mice.
    Miguel DC; Ferraz ML; Alves Rde O; Yokoyama-Yasunaka JK; Torrecilhas AC; Romanha AJ; Uliana SR
    Mem Inst Oswaldo Cruz; 2010 Nov; 105(7):945-8. PubMed ID: 21120371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.